Empagliflozin
- Introduction
- Newest Products
Introduction
Empagliflozin
Empagliflozin is an inhibitor of SGLT2 for the treatment of type II diabetes, which causes sugar in the blood to be excreted by the kidneys and eliminated in urine.
Newest Products
| Image | Part # | Description | manufacturer | Stock | RFQ | |
|---|---|---|---|---|---|---|
|
|
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran (915095-89-5) |
CAS: 915095-89-5; Empagliflozin manufacturer; Empagliflozin intermediates; Diabetics
|
|
In Stock
|
|
|
|
|
(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one (32384-65-9) |
CAS: 32384-65-9; Empagliflozin manufacturer; Empagliflozin intermediates; Diabetics
|
|
In Stock
|
|
|
|
|
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran (915095-94-2) |
CAS: 915095-94-2; Empagliflozin manufacturer; Empagliflozin intermediate; Diabetics
|
|
In Stock
|
|
|
|
|
Acetoxy Empagliflozin (Empagliflozin N-1) (915095-99-7) |
CAS: 915095-99-7; Empagliflozin manufacturer; Empagliflozin intermediates; Diabetics
|
|
In Stock
|
|
|
|
|
Empagliflozin (864070-44-0) |
CAS: 864070-44-0; Empagliflozin manufacturer; Diabetics
|
|
In Stock
|
|
